Cargando…
Clinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes
BACKGROUND: Even though several oral anti-diabetic drugs (OAD) with various modes of action are replacing sulfonylurea (SU), some patients seem to be dependent on SU for adequate glycemic control. Therefore, we evaluated the clinical characteristics of such patients. METHODS: We selected the patient...
Autores principales: | Min, Se Hee, Kwak, Soo Heon, Cho, Young Min, Park, Kyong Soo, Jung, Hye Seung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722406/ https://www.ncbi.nlm.nih.gov/pubmed/26354492 http://dx.doi.org/10.3803/EnM.2015.30.4.509 |
Ejemplares similares
-
1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy
por: Kim, Min Kyeong, et al.
Publicado: (2016) -
Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes
por: Oh, Tae Jung, et al.
Publicado: (2013) -
Response: Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased β-Cell Function Similar to Impaired Glucose Tolerance (Diabetes Metab J 2015;39:147-53)
por: Oh, Tae Jung, et al.
Publicado: (2015) -
Vildagliptin reduces plasma stromal cell‐derived factor‐1α in patients with type 2 diabetes compared with glimepiride
por: Park, Kyeong Seon, et al.
Publicado: (2016) -
Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin
por: Kim, Ye An, et al.
Publicado: (2015)